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MicroRNAs (miRNAs) play functional roles in sound transduction in cochleae. This study 
focuses on the validity of cochlear culture as an in vitro experimental tool, in view of 
miRNA expression. E15 cochleae were dissected and maintained in vitro for 48 hr before 
extraction of micro RNAs. MiRNA expression was comprehensively screened in 
explanted cochleae using a miRNA array that covers 380 miRNAs. Strong correlation 
was observed between expression levels of miRNAs in vitro and those in in vivo 
cochleae. Levels of 43 miRNAs were altered in vitro and these changes were 
reproducible over three trials. These findings indicate that in vitro miRNA profiling is a 








Cochlear culture is a useful tool to investigate the expression of genes [1] and the 
actions of chemical compounds in the cochlea. For example, it has been applied for 
investigations of cochlear-specific gene expressions [1] and action of dexamethasone on 
cochlear tissue [2]. Recent studies have found that the expression of particular 
microRNAs (miRNAs) plays critical roles in cochlea function [3-8]. We have already 
reported that mRNA expression in cochlear explants is well-preserved under the in vitro 
experimental conditions, as shown by DNA microarray assay [2]. However, the 
mechanism by which the expression of miRNAs is maintained in vivo is unknown. As a 
first step, it is important to test the validity of cochlear culture in view of miRNA 
expression as an in vitro experimental tool. In this study, the expression of miRNAs in 
cochlear explants was comprehensively evaluated using a miRNA array that covers 380 
miRNAs, and the miRNAs were compared between in vitro and in vivo conditions.  
 
Methods  
Tissue dissection and culture of mouse cochleae  
Timed pregnant female BALB/c mice were sacrificed using an excess of ketamine (150 
mg/kg, intraperitoneal) on E15 (vaginal plug, E0). The fetal cochleae were immediately 
dissected under a binocular microscope and frozen in liquid nitrogen until total RNA 
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extraction, or placed into Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 5% KnockOut Serum Replacement (Invitrogen, Carlsbad, CA, USA) and penicillin 
G (0.06 mg/ml). The explanted cochlea included the cochlear duct and immature sensory 
epithelium, nonneuronal mesenchymal tissues, lateral wall of the cochlea and spiral 
neurons [2].  
 Explanted cochleae were placed in 250 μl of serum-free medium and maintained at 
37ºC in 5% CO2, with daily serum changes. Explanted cochleae were maintained in vitro 
for 48 hr (DIV2) before extraction of total RNA. In general, 12-14 cochleae from a single 
litter were processed in each sample. All experimental protocols complied with the 
guidelines of Okayama University’s Committee on the Use and Care of Animals. 
Comprehensive analysis of microRNA expression in cochlear tissue 
To screen miRNA expression in the explanted cochleae, we performed a microarray 
analysis using mirVana
TM
 miRNA Bioarray V9.2 (Filgen, Inc., Aichi, Japan).This 
microarray carries the nucleotides for a total of 380 miRNAs with each miRNA spotted in 
quadruplicate. MiRNA purification and other experimental procedures were performed as 
follows.  
MiRNA purification and labeling 
Total RNA was extracted from the in vitro and in vivo cochlear tissue using an RNA-easy 
column (Qiagen, Hilden, Germany). The quality of the purified RNA was checked using 
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an Agilent 2100 Bioanalyzer (Agilent Technologies, Tokyo, Japan). Using the flash 
PAGE
TM
 system (Ambion Inc., Austin, TX, USA), we purified the miRNAs from 22 μg of 
total RNA. The purified miRNA was labeled using a mirVana
TM
 miRNA Labeling Kit 
(Ambion, Inc.) and CyDye Mono-Reactive Dye Pack (GE Healthcare Bio-science Corp, 
Piscataway, NJ, USA) according to the manufacturer’s protocol.  
Hybridization to miRNA array and data analysis  
The labeled miRNAs were dissolved in 1× miRNA Hybridization buffer, incubated for 3 
min at 95°C and then cooled to room temperature before application onto the arrays. The 
arrays were then incubated for 16–20 hr at 42°C. After hybridization, the arrays were 
washed once with low stringency wash (nuclease-free water 376 ml, detergent 
concentrate 4 ml, salt concentrate 20 ml) for 30 sec and twice with high stringency wash 
(nuclease-free water 780 ml, salt concentrate 20 ml) for 30 sec. After the arrays were 
centrifuged at 600×g for 5 min for drying, they were scanned using a GenePix 4000B
®
 
scanner (Axon Instruments, Sunnyvale, CA, USA) and the signal data of each array was 
calculated using an Array-Pro Analyzer
®
 Ver.4.5 (Media Cybernetics Inc., Bethesda, MD, 
USA). The array data was normalized and averaged using the Microarray Date Analysis 
Tool (Filgen, Nagoya, Japan). All the experiments, including tissue dissection, cochlear 
culture, and miRNA extraction on the array, were performed three times to test the 





The overall correlation of the expression of the 380 miRNAs between the in vitro and in 
vivo cochleae was very high (r =0.902, p <0.001) (Figure 1). However, several miRNAs 
were expressed differently in cochlear culture. Among these, 27 miRNAs had increased 
by more than 2-fold, and 37 miRNAs had decreased to less than half, in the in vitro 
cochlear tissue compared to the in vivo cochleae in the first trial of the experiment. In the 
second trial, the expression levels of 30 miRNAs had increased and that of 43 miRNAs 
had decreased, while in the third trial, 29 miRNAs had increased and 40 miRNAs had 
decreased. In each of the 3 trials, the expression level of 19 particular miRNAs always 
increased by more than 2-fold and that of 23 particular miRNAs always decreased to less 




The present data demonstrates that the overall expression levels of miRNAs before and 
after explantation are strongly correlated. A small number of miRNAs demonstrated 
differential expression after explantation but these changes in the expression levels 
occurred with striking reproducibility throughout the three trials. Our data validates the 
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use of cochlear explants as a model to investigate gene expression and the actions of 
various chemical compounds on cochlear tissue.  
In this study, the expression level of 19 miRNAs increased while that of 23 miRNAs 
decreased in vitro in all 3 trials with 100% reproducibility.  
Among them, the expression level of miR-762 (Gene ID: 791073) always decreased. 
This miRNA is known to interact and inactivate the expression of Hsf1 (Gene ID: 15499, 
Heat-shock factor 1, Microcosm Targets, URL: 
http://www.ebi.ac.uk/enright-srv/microcosm). This protein activates heat-shock response 
genes under conditions of heat or other stresses such as hypoxia [9]. We previously 
examined mRNA expression in cochlear explants and reported that the expression level 
of Gapdh is increased in explanted cochleae, indicating that cochlear tissue in culture is 
in a state of relative hypoxia [1]. We believe that the expression level of miR-762 may 
have changed in response to the hypoxic conditions.  
The expression levels of MiR-22 (Gene ID: 387141) and miR-683 (Gene ID: 751559) 
decreased in all three trials of the experiment. MiR-22 is known to interact and inactivate 
the expression of Dad1 (Gene ID: 13135, Defender against cell death 1, Microcosm 
Targets). MiR-683 is known to interact and inactivate the expression of Aven (Gene ID: 
74268, Apoptosis, caspase activation inhibitor, Microcosm Targets). These proteins have 
been shown to play roles in preventing apoptotic cell death [10,11], suggesting that the 
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reduction in the expression levels of miR-22 and miR-683 may lead to prevention of 
apoptotic cell death. These miRNAs are thought to be regulated in cochlear explants as 
a protective response to the exposure of the tissue to in vitro conditions.  
 
Conclusion  
The present data demonstrated strong correlation in the expression levels of miRNAs 
between in vitro and in vivo cochleae (r=0.902, p<0.001). The levels of 43 of the 380 
miRNAs screened were altered in vitro but these changes were highly reproducible over 
the three experimental trials. These finding indicate the validity of using cochlear 
explants for investigations regarding gene expression and the actions of various 
chemical compounds on the cochlea.  
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Legends  
Figure 1. Overall levels of microRNA expression in the cochlear before and after 
explantation. The overall expression levels of the 380 miRNAs were highly correlated 
between the in vitro and in vivo cochleae (r =0.902, p <0.001).  
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Table 1. MicroRNAs increased by more than 2-fold, or decreased to less than half in the 
in vitro cochleae compared to the in vivo cochleae.  
The expression of 19 miRNAs was upregulated by more than 2-fold, and those of 23 
miRNAs were downregulated to less than half in vitro, compared to the levels in vivo. 




microRNAs increased microRNAs decreased
more than 2 fold in vitro ratio of normalized intensity. less than 0.5 fold in vitro ratio of normalized intensity.
(RefSeq ID) first trial second trial third trial (RefSeq ID) first trial second trial third trial
miR_20a 2.03 2.46 2.33 miR_224 0.24 0.43 0.38
miR_106b 2.29 2.93 2.56 miR_297 0.09 0.07 0.04
miR_92 2.76 2.64 2.83 miR_341 0.23 0.23 0.24
miR_181a 2.16 2.06 2.20 miR_34a 0.33 0.38 0.40
miR_106a 2.13 2.54 2.35 miR_22 0.36 0.34 0.40
miR_18 3.62 5.12 5.12 miR_346 0.17 0.12 0.14
miR_19b 2.49 2.75 2.91 miR_468 0.04 0.03 0.02
miR_19a 2.50 2.01 2.88 miR_370 0.49 0.48 0.41
miR_124a 5.82 7.71 6.76 miR_210 0.30 0.35 0.32
miR_126-3p 3.82 5.31 3.52 miR_204 0.19 0.15 0.40
miR-301 2.52 2.00 4.04 miR_122a 0.16 0.12 0.10
miR_20b 2.09 2.63 2.45 miR_26b 0.34 0.23 0.47
miR_503 2.72 2.91 3.21 let_7f 0.29 0.26 0.40
miR_302c 2.44 2.25 3.76 miR_669b 0.05 0.04 0.03
miR_720 2.22 2.20 2.51 miR_679 0.35 0.47 0.35
miR_690 2.63 3.01 2.31 miR_297b 0.11 0.07 0.05
miR_138 4.59 4.74 3.57 miR_683 0.27 0.23 0.35
miR_301b 2.38 2.79 4.13 miR_669c 0.03 0.02 0.02
miR_804 3.10 3.61 4.00 miR_669a 0.08 0.06 0.05
miR-711 0.43 0.28 0.37
miR-672 0.14 0.10 0.07
miR-762 0.37 0.35 0.24
miR-760 0.46 0.47 0.35
list of microRNAs
reproducible in 3 isolated
trials
 
